Related Experiment Videos
A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model
L Kong1, J G Smith, D Bramhill
1Department of Enzymology, Merck Research Laboratories, Merck and Co., Inc, Rahway, New Jersey 07065-0900, USA.
Clinical and Diagnostic Laboratory Immunology
|January 1, 1996
Summary
A new PCR method accurately detects and quantifies Helicobacter felis in mouse models. This improved Helicobacter detection enhances therapeutic evaluations and antibiotic discovery for Helicobacter ulcer disease.
Area of Science:
- Microbiology
- Molecular Biology
- Animal Models
Background:
- Limited sensitivity and specificity of current detection methods for Helicobacter colonization in small animal models.
- Need for improved Helicobacter felis mouse models for accurate therapeutic regimen evaluation.
Purpose of the Study:
- To develop a Polymerase Chain Reaction (PCR) for detecting and quantitatively measuring H. felis in viral antibody-free (VAF) mice.
- To establish a more sensitive and specific Helicobacter detection method for small animal models.
Main Methods:
- Developed a PCR assay targeting the H. felis 16S rRNA gene.
- Utilized competitive PCR with an internal control DNA for quantitative analysis.
- Infected VAF mice with H. felis and collected stomach mucosa for PCR analysis at various time points.
- Confirmed H. felis colonization through culture isolation and histological examination.
Main Results:
- The developed PCR method detected approximately 50 to 100 H. felis cells per mouse stomach.
- The PCR assay demonstrated no cross-reactivity with other common mouse stomach bacteria.
- Therapeutic response in the H. felis mouse model correlated well with human clinical trial results for H. pylori.
Conclusions:
- A novel PCR-based detection and quantification method for H. felis in mouse models has been successfully developed.
- This enhanced Helicobacter detection model offers improved accuracy for evaluating therapeutic regimens.
- The model is suitable for discovering new antibiotics and vaccines against Helicobacter ulcer disease.